William Schuyler Jones, MD

Associate Professor of Medicine
Associate Professor in Population Health Sciences
Member of the Duke Clinical Research Institute
Campus mail 2400 Pratt Street, 7037, Durham, NC 27705
Phone (919) 668-8917
Email address schuyler.jones@duke.edu

I am an interventional cardiologist with a specific focus on the diagnosis and treatment of patients with vascular disease, and I perform coronary and peripheral angiography and interventions. I have a broad background in cardiovascular site-based research, multicenter clinical trials, clinical event classification, and observational analyses.  Currently, I am helping to lead a Duke Clinical Research Institute (DCRI) effort to coordinate a multinational, multicenter randomized clinical trial evaluating antiplatelet agents in the treatment of patients with peripheral artery disease. I have served as a physician reviewer for the
Clinical Events Classification (CEC) group at the DCRI and have been the Assistant Director of CEC since 2015. I am also the medical director of the Duke Heart Center Clinical Research Unit that manages each clinical research cluster including Cath Lab, EP, Heart Failure, General Cardiology, and Imaging.

In Their Words

Education and Training

  • Fellow in Cardiology, Medicine, Duke University, 2004 - 2005
  • Medical Resident, Medicine, Duke University, 2001 - 2004
  • M.D., University of Arkansas at Little Rock, 2001

Publications

Marquis-Gravel, G, Thiele, H, Jones, WS, Smalling, RW, Cohen, M, Perera, D, Pijls, N, Fanaroff, A, Brucker, A, Chiswell, K, Patel, MR, and Ohman, EM. "Size of Anterior Wall Acute Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention in United States Versus Europe/Australia Versus India (from the CRISP-AMI Randomized Controlled Trial)." The American Journal of Cardiology 123, no. 7 (April 2019): 1026-1034.

PMID
30642606
Full Text

Goldsweig, AM, Kennedy, KF, Abbott, JD, Jones, WS, Velagapudi, P, Rutar, FJ, Curtis, JC, Tsai, TT, and Aronow, HD. "Patient Radiation Dosage During Lower Extremity Endovascular Intervention." Jacc. Cardiovascular Interventions 12, no. 5 (March 2019): 473-480.

PMID
30846087
Full Text

Fanaroff, AC, Clare, R, Pieper, KS, Mahaffey, KW, Melloni, C, Green, JB, Alexander, JH, Jones, WS, Harrison, RW, Mehta, RH, Povsic, TJ, Moreira, HG, Al-Khatib, SM, Roe, MT, Kong, DF, Mathews, R, Tricoci, P, Holman, RR, Wallentin, L, Held, C, Califf, RM, Alexander, KP, and Lopes, RD. "Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 Trials." Circulation 139, no. 7 (February 2019): 863-873.

PMID
30586739
Full Text

Jang, JJ, Bhapkar, M, Coles, A, Vemulapalli, S, Fordyce, CB, Lee, KL, Udelson, JE, Hoffmann, U, Tardif, J-C, Jones, WS, Mark, DB, Sorrell, VL, Espinoza, A, Douglas, PS, Patel, MR, and PROMISE Investigators, . "Predictive Model for High-Risk Coronary Artery Disease." Circulation. Cardiovascular Imaging 12, no. 2 (February 2019): e007940-null.

PMID
30712364
Full Text

Doll, JA, Jones, WS, Lokhnygina, Y, Culpepper, S, Parks, RL, Calhoun, C, Au, DH, and Patel, MR. "PREPARED Study: A Study of Shared Decision-Making for Coronary Artery Disease." Circulation. Cardiovascular Quality and Outcomes 12, no. 2 (February 2019): e005244-null.

PMID
30764651
Full Text

Kansal, A, Long, CA, Patel, MR, and Jones, WS. "Endovascular treatment of femoro-popliteal lesions." Clinical Cardiology 42, no. 1 (January 2019): 175-183. (Review)

PMID
30324655
Full Text

Olivier, CB, Mulder, H, Hiatt, WR, Jones, WS, Fowkes, FGR, Rockhold, FW, Berger, JS, Baumgartner, I, Held, P, Katona, BG, Norgren, L, Blomster, J, Patel, MR, and Mahaffey, KW. "Incidence, Characteristics, and Outcomes of Myocardial Infarction in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial." Jama Cardiology 4, no. 1 (January 2019): 7-15.

PMID
30540355
Full Text

Rogers, RK, Hiatt, WR, Patel, MR, Shishehbor, MH, White, R, Khan, ND, Bhalla, NP, Jones, WS, and Low Wang, CC. "Ticagrelor in Peripheral Artery Disease Endovascular Revascularization (TI-PAD): Challenges in clinical trial execution." Vascular Medicine (London, England) 23, no. 6 (December 2018): 513-522.

PMID
29629845
Full Text

Berger, JS, Abramson, BL, Lopes, RD, Heizer, G, Rockhold, FW, Baumgartner, I, Fowkes, FGR, Held, P, Katona, BG, Norgren, L, Jones, WS, Millegård, M, Blomster, J, Reist, C, Hiatt, WR, Patel, MR, and Mahaffey, KW. "Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial." Vascular Medicine (London, England) 23, no. 6 (December 2018): 523-530.

PMID
29992857
Full Text

Shishehbor, MH, White, CJ, Beckman, JA, Misra, S, Schneider, PA, Lookstein, RA, Kashyap, VS, Clair, D, Jones, WS, Rosenfield, K, Katzen, BT, and Jaff, MR. "Centers for Medicare & Medicaid Services' decision on drug-coated balloons: No additional reimbursement despite higher cost and highest levels of scientific evidence." Vascular Medicine (London, England) 23, no. 6 (December 2018): 558-559.

PMID
30238852
Full Text

Pages